ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

Clinical trials for ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy shows promise for older hodgkin patients

Disease control Completed

This study tested a new combination treatment for older adults (age 60+) with untreated Hodgkin lymphoma. Participants received a targeted drug called brentuximab vedotin along with standard chemotherapy (AVD). The goal was to see if this approach could increase the number of pat…

Matched conditions: ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Jun 15, 2026 19:06 UTC

ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

Get alerted when new ADULT LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA trials appear

New combo therapy shows promise for older hodgkin patients